Study in The Lancet successfully demonstrated endpoints of identifying both vulnerable patients & plaques at a significantly higher risk for subsequent MACE. View now View Now

Together, we are fighting Coronary Artery Disease because the heart is everything.

WATCH VIDEO

Reduce blood loss with the OKAY® II Y-Connector

#1 selling Y-Connector in Japan.
Now available in the US.
View Product Details

Logo

Now FDA indicated to identify plaque and patients at increased risk of MACE.

Achieve unparalleled insights with the Makoto™ Imaging System and its accompanying Dualpro™ IVUS + NIRS catheter, the only FDA-cleared dual-modality catheter and imaging system indicated for the identification of patients and plaques at increased risk of major adverse cardiac events (MACE).

Explore the

LRP STUDY RESULTS

 

See the Makoto™

SYSTEM IN ACTION

 

Discover the

IVUS+NIRS TECHNOLOGY

 

Don’t waste an opportunity of being inside the patient’s vessel

Bring the Makoto Intravascular Imaging System to your institution today and gain unparalleled insights about your patient’s vessel health.

SIGN UP NOW

#1 selling Y-Connector in Japan.
Now available in the US.
View Product Details Request Quote

Rotablator™ trademark is not owned by Infraredx, a Nipro company and is attributed to the company.

LRP: Assessment of Coronary Near-Infrared Spectroscopy Imaging to Detect Vulnerable Plaques and Vulnerable Patients

View LRP Study Overview View The Lancet LRP Study

We are Pioneers

developing solutions aimed at conquering vascular disease

SEE WHAT IT TAKES

© 2020 Infraredx™, Inc. All Rights Reserved Powered by Bloom Creative